Population Pharmacokinetics of Posaconazole in Immune-Compromised Children and Assessment of Target Attainment in Invasive Fungal DiseaseSean McCann, Daniel González, Jaydeep Sinha et al.|Clinical Pharmacokinetics|2023Cited by 10
Application of Physiologically Based Pharmacokinetic Modeling to Characterize the Effects of Age and Obesity on the Disposition of Levetiracetam in the Pediatric PopulationPatricia D. Maglalang, Lauri Filar, Amira Al‐Uzri et al.|Clinical Pharmacokinetics|2024Cited by 5
Pharmacokinetics of Dexamethasone in Children and Adolescents with ObesityJiali Wen, Daniel González, Sean McCann et al.|The Journal of Clinical Pharmacology|2024Cited by 4
Using Real‐World Data to Externally Evaluate Population Pharmacokinetic Models of Dexmedetomidine in Children and InfantsSean McCann, Daniel González, Victória Etges Helfer et al.|The Journal of Clinical Pharmacology|2024Cited by 3
Physiologically Based and Population Pharmacokinetic Modeling of Midazolam in Children With Obesity Using Real‐World DataSean McCann, Daniel González, Victória Etges Helfer et al.|Clinical and Translational Science|2025Cited by 3